SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-13-011824
Filing Date
2013-02-19
Accepted
2013-02-19 16:57:25
Documents
3
Group Members
CHIESI U.S. CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a13-5477_1sc13da.htm SC 13D/A 192421
2 EX-13 a13-5477_1ex13.htm EX-13 16608
3 GRAPHIC g54771kii001.jpg GRAPHIC 3985
  Complete submission text file 0001104659-13-011824.txt   216216
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79887 | Film No.: 13624099
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA PALERMO 26/A PARMA L6 43122
Business Address VIA PALERMO 26/A PARMA L6 43122 39.0521.279.1
Chiesi Farmaceutici SpA (Filed by) CIK: 0001464415 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A